• A. G. Niethammer
  • F. W. Hensley


Die myeloablative Ganzkörperbestrahlung ist Teil einer interdisziplinären Gesamtbehandlung einer Reihe unterschiedlicher maligner Erkrankungen des internistischen und des pädiatrischen Formenkreises.


  1. AAPM Task Group 29: Van Dyk J, Galvin JM, Glasgow GP, Podgorsak EB (1986) The physical aspects of total and half body photon irradiation. AAPM Report No. 17. Medical Physics Publishing, Madison, WisconsinGoogle Scholar
  2. Ayash LJ, Hunt M, Antman K et al. (1990) Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas. J Clin Oncol 8(10):1699–1706PubMedGoogle Scholar
  3. Bamberg M, Beelen DW, Mahmoud HK, Molls M, Schaefer UW (1986) The incidence of interstitial pneumonitis: comparison of total body irradiation schedules for allogenic bone marrow transplantation. Strahlenther Onkol 162(4):218–222PubMedGoogle Scholar
  4. Barrett A, Depledge MH, Powles RL (1983) Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation. Int J Radiat Oncol Biol Phys 9(7):1029–1033PubMedCrossRefGoogle Scholar
  5. Benyunes MC, Sullivan KM, Deeg HJ et al. (1995) Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation. Int J Radiat Oncol Biol Phys 32(3):661–670PubMedCrossRefGoogle Scholar
  6. Bergstein J, Andreoli SP, Provisor AJ, Yum M (1986) Radiation nephritis following total-body irradiation and cyclophosphamide in preparation for bone marrow transplantation. Transplantation 41(1):63–66PubMedCrossRefGoogle Scholar
  7. Buchali A, Feyer P, Groll J, Massenkeil G, Arnold R, Budach V (2000) Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation. Radiother Oncol 54(2):157–162PubMedCrossRefGoogle Scholar
  8. Chou RH, Wong GB, Kramer JH et al. (1996) Toxicities of totalbody irradiation for pediatric bone marrow transplantation. Int J Radiat Oncol Biol Phys 34(4):843–851PubMedCrossRefGoogle Scholar
  9. Deeg HJ (1990) Delayed complications and long-term effects after bone marrow transplantation. Hematol Oncol Clin North Am 4(3):641–657PubMedGoogle Scholar
  10. Galvin JM, D’Angio GJ, Walsh G (1980) Use of tissue compensators to improve the dose uniformity for total body irradiation. Int J Radiat Oncol Biol Phys 6:767–771PubMedCrossRefGoogle Scholar
  11. Hall P, Adami HO, Trichopoulos D et al. (2004) Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. BMJ 328(7430):19PubMedCrossRefGoogle Scholar
  12. International Commission on Radiation Units and Measurements (1993) ICRU Report 50: Prescribing, recording and reporting photon beam therapy. 7910 Woodmont Avenue, Bethesda, Maryland 20814, USAGoogle Scholar
  13. Jensen JM, Brix F, Kohr P (1986) General and specific aspects of experimental dose measurement in total body irradiation (TBI). Strahlenther Oncol 162:250–253Google Scholar
  14. Keilholz U, Korbling M, Fehrentz D, Bauer H, Hunstein W (1989) Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders. Cancer 64(3):641–645PubMedCrossRefGoogle Scholar
  15. Kuphal K (1986) Dosimetric problems associated with total body irradiation. Strahlenther Oncol 162:260–265Google Scholar
  16. Leung PM, Rider WD, Webb HP, Aget H, Johns HE (1981) Co-balt-60 therapy unit for large field irradiation. Int J Radiat Oncol Biol Phys 7:705–712PubMedCrossRefGoogle Scholar
  17. Lohr F, Wenz F, Schraube P et al. (1998) Lethal pulmonary toxicity after autologous bone marrow transplantation/peripheral blood stem cell transplantation for hematological malignancies. Radiother Oncol 48(1):45–51PubMedCrossRefGoogle Scholar
  18. Lowsky R, Lipton J, Fyles G et al. (1994) Secondary malignancies after bone marrow transplantation in adults. J Clin Oncol 12(10):2187–2192PubMedGoogle Scholar
  19. Lutz W, Dougan PW, Bjarngard BE (1988) Design and characteristics of a facility for total body and large field irradiation. Int J Radiat Oncol Biol Phys 15:1035–1040PubMedCrossRefGoogle Scholar
  20. Melzer R, Wolf U, Szafinski F, Schneider R, Fischer S (1994) Die neue Ganzkörperbestrahlungseinrichtung zur Vorbereitung der Knochenmarktransplantation in der Klinik für Strahlentherapie der Universität Leipzig. In: Tautz M (Hrsg) Medizinische Physik 94. Jahrestagung der Deutschen Gesellschaft für Medizinische Physik, Erfurt 21.–24. September 1994. Deutsche Gesellschaft für Medizinische Physik, 12–13Google Scholar
  21. Peper M, Steinvorth S, Schraube P et al. (2000) Neurobehavioral toxicity of total body irradiation: a follow-up in longterm survivors. Int J Radiat Oncol Biol Phys 46(2):303–311PubMedCrossRefGoogle Scholar
  22. Phillips GL, Fay JW, Herzig RH et al. (1990) The treatment of progressive non-Hodgkin’s lymphoma with intensive chemoradiotherapy and autologous marrow transplantation. Blood 75(4):831–838PubMedGoogle Scholar
  23. Phillips GL, Herzig RH, Lazarus HM et al. (1984) Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. N Engl J Med 310(24):1557–1561PubMedCrossRefGoogle Scholar
  24. Podgorsak EB, Podgorsak MB (1999) Special Techniques in Radiatiotherapy. In: Van Dyk J (ed) The modern technology of radiation oncology. A compendium for medical physicists and radiation oncologists. Medical Physics Publishing, Madison, Wisconsin, 641–662Google Scholar
  25. Pui CH, Cheng C, Leung W et al. (2003) Extended follow-up of long-term survivors of childhood acute lymphoblastic leukaemia. N Engl J Med 349(7):640–649. Erratum in: N Engl J Med 349(13):1299Google Scholar
  26. Van Dyk J, Keane TJ, Kan S, Rider WD, Fryer CJH (1981) Radiation pneumonitis following large single dose irradiation: a re-evaluation based on absolute dose to lung. Int J Radiat Oncol Biol Phys 7:461–467PubMedCrossRefGoogle Scholar
  27. Van Dyk J, Mah K, Keane TJ (1989) Radiation-induced lung damage: dose-time-fractionation considerations. Radiother Oncol 14:55–69PubMedCrossRefGoogle Scholar
  28. Quast U (1985) Physical treatment planning for total body irradiation: Patient translation and beam-zone method. Med Phys 12:567–574PubMedCrossRefGoogle Scholar
  29. Quast U (1987) Total body irradiation – review of treatment techniques in Europe. Radiother Oncol 9:91–106PubMedCrossRefGoogle Scholar
  30. Rozman C, Carreras E, Qian C et al. (1996) Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Transplant 17(1):75–80PubMedGoogle Scholar
  31. Rubin P, Salazar O, Zagars G, Constine LS, Keys H, Poulter CA, Van Ess JD (1985) Systemic hemibody irradiation for overt and occult metastases. Cancer 55(Suppl 9):2210–2221PubMedCrossRefGoogle Scholar
  32. Salazar OM, Sandhu T, da Motta NW et al. (2001) Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA). Int J Radiat Oncol Biol Phys 50(3):765–775PubMedCrossRefGoogle Scholar
  33. Sanders JE, Buckner CD, Leonard JM et al. (1983) Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 36(3):252–255PubMedCrossRefGoogle Scholar
  34. Sanders JE, Hawley J, Levy W et al. (1996) Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87(7):3045–3052PubMedGoogle Scholar
  35. Sanders JE (1990) Late effects in children receiving total body irradiation for bone marrow transplantation. Radiother Oncol (Suppl 1):82–87Google Scholar
  36. Shank B (1983) Techniques of Magna-Field Irradiation. Int J Radiat Oncol Biol Phys 9:1925–1931PubMedCrossRefGoogle Scholar
  37. Sklar CA, Kim TH, Ramsay NK (1982) Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am J Med 73(5):688–694PubMedCrossRefGoogle Scholar
  38. Stone RM, Neuberg D, Soiffer R et al. (1994) Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin’s lymphoma. J Clin Oncol 12(12):2535–2542PubMedGoogle Scholar
  39. Thomas E, Storb R, Clift RA et al. (1975) Bone-marrow transplantation (first of two parts). N Engl J Med 292(16):832–843PubMedCrossRefGoogle Scholar
  40. Van Dyk J (1983) Magna-field irradiation: physical considerations. Int J Radiat Oncol Biol Phys 9:1913–1918PubMedCrossRefGoogle Scholar
  41. Van Dyk J (1987) Dosimetry for total body irradiation. Radiother Oncol 9:107–118PubMedCrossRefGoogle Scholar
  42. Villela L, Sureda A, Canals C et al. (2003) Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation. Haematologica 88(3):300–305PubMedGoogle Scholar
  43. Zierhut D, Lohr F, Schraube P et al. (2000) Cataract incidence after total-body irradiation. Int J Radiat Oncol Biol Phys 46(1):131–135PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • A. G. Niethammer
    • 1
  • F. W. Hensley
    • 2
  1. 1.Pfizer Inc.San DiegoUSA
  2. 2.Abteilung Radioonkologie und StrahlentherapieRadiologische KlinikHeidelbergDeutschland

Personalised recommendations